openPR Logo
Press release

Tetanus Toxoid Vaccine Market

03-01-2019 01:51 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

/ PR Agency: Market Research Future
Tetanus Toxoid Vaccine Market

Tetanus Toxoid Vaccine Market

The report for Global Tetanus Toxoid Vaccine Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance.

Market Highlights:

Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone fractures. Other symptoms include fever, sweating, headache, trouble swallowing, hypertension etc. About 10% of those infected, die while a large number become incapacitated due to bone fractures. Tetanus toxoid vaccine is an inactive vaccine used to prevent tetanus by developing immunity against the pathogen causing tetanus. The general dosage recommendation is five doses during childhood, with a sixth given during adolescence with additional doses every 10 years. The tetanus vaccine was initially developed in 1924 and has resulted in a 95% decrease in the rate of tetanus in the US and is on the World Health Organization's List of Essential Medicines. The vaccine also is considered very safe even during pregnancy and for those with HIV.

Get Premium Sample Copy of Tetanus Toxoid Vaccine Market Report spread across 90 Premium Pages, 11 Companies is Now Available @ www.marketresearchfuture.com/sample_request/4024 .

The Tetanus Toxoid Vaccine Market is expected to reach $ 5.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.3 % during 2017-2023.

The market restraints of the tetanus toxoid vaccine are redness and pain at the site of injection, fever, and fatigue and muscles pains. Severe allergic reactions are the most serious side effects of the Tetanus toxoid vaccine which occur in less than one in 100,000 people. The market for tetanus toxoid vaccine is bipolar with contractual market having a sizable number of share as compared to the private market. The other market constraints include falling profitability of vaccine manufacturing, huge reduction of tetanus in the developed world which effectively eliminates the need for further vaccination due to herd immunity, side effects associated with vaccines, variability of efficacy of tetanus toxoid vaccine etc.

The low profitability in vaccine manufacturing has reduced incentives for developing vaccines for diseases of the developing world such as tuberculosis and malaria.

Key players of Global Tetanus Toxoid Vaccine Market:

GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech, Shenzhen Kangtai Biological Products, Valeant Pharmaceuticals, Emergent Biosolutions Inc., Astellas Pharma Inc., Panacea Biotec and others.

Segments:

The Global Tetanus Toxoid Vaccine Market is segmented on the basis of types, forms and end users. Based on types, the market has been segmented as monovalent tetanus toxoid (TT), diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (Tdap) and others. Based on the forms, the market has been segmented as quadrivalent, pentavalent, and hexavalent. Based on the end users, the market has been segmented as biotech and hospitals and clinics, government organizations, research and others.

Regional analysis

US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global Tetanus toxoid vaccine. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tetanus Toxoid Vaccine Market here

News-ID: 1626923 • Views: 181

More Releases from Market Research Future

Odontogenic Tumor Market - Leading Growth Drivers, Emerging Trends, Segments, Si …
Odontogenic Tumor Market Highlights The odontogenic tumor is the abnormal growth of cells in and around the jaws and teeth. Many of these tumors are considered to be benign. In usual cases, odontogenic tumors are malignant means they are likely to spread in jaws and teeth. This tumor can be diagnosed using different techniques such as computerized tomography scan (also called a CT or CAT scan), magnetic resonance imaging (MRI),
Active Pharmaceutical Ingredients Market 2018 Global Analysis, Opportunities And …
Active Pharmaceutical Ingredients Market Expected to Witness a Steady Rise The drugs that we use, such as tablets, injectables, syrups, and capsules) are an amalgamated combination Active Pharmaceutical Ingredients (API) and excipients. It is a chemical or a drug which is responsible for the therapeutic and pharmacological activities in the human body. It is the most important ingredient in a drug that helps treat a disorder or a disease when administered.
Application Performance Management (APM) Market 2019 Top Key Players: IBM Corpor …
Application Performance Management Market Highlights: Tools and processes responsible for monitoring and managing the performance and availability of software applications. Application performance management (APM) tools alert IT staff to disruptions in availability and/or quality to end users when accessing mission-critical applications. Applications monitored by APM tools can include traditional non-connected applications, Web-enabled applications, streaming apps, and cloud applications. An application-centric manner is the ability to identify, diagnose and repair problems quickly, which
Plastic Container Market 2019 Global Industry Analysis By Share, Key Company, Tr …
Market Synopsis of Plastic Container Market. Plastic containers are one of the most used and preferred packaging material all over the world and can readily be molded into a variety of products that can be used in a wide range of applications. Plastic packaging refers to numerous products such as plastic bottles & food containers, pouches among others. They are generally made up of plastic resins such as PET, PP, and

All 46507 Releases


More Releases for Tetanus

Tetanus Therapeutics- Pipeline Analysis 2018 | Zydus Group
Tetanus, also known as lockjaw is a bacterial disease caused by Clostridium tetani. The bacteria are usually found in dust, soil, and manure and enter the body through breaks in the skin. The spores develop into bacteria when they enter the body. Download the sample report @ https://www.pharmaproff.com/request-sample/1074 These spores can get into the body through broken skin, usually through injuries from contaminated objects. Certain breaks in the skin are more
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various
Trends in the Tetanus Market 2016-2026
Tetanus also known as lockjaw, is an acute disease caused by the bacterium clostridium tetani which are present in the environment and particularly found in the soil of moist and warm areas. It is characterized by convulsive spasms and generalized rigidity of the skeletal muscles. The muscles stiffness is found to be occurred in the jaw and neck first and then become generalized. During the early 1920’s a method for
Tetanus-Pipeline Review H1 2017
ReportsWeb.com has announced the addition of the “Tetanus-Pipeline Review H1 2017” this report provides an overview of the Tetanus-Pipeline landscape. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H1 2017, provides an overview of the Tetanus (Infectious Disease) pipeline landscape. Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles, difficulty swallowing, stiffness of abdominal muscles, fever,
World Diphtheria Treatment Market by Tetanus Immune Globulin, Tetanus Toxoid, Te …
The Global Diphtheria Treatment Market report titled “Diphtheria Treatment Market Research Report- Global Forecast Till 2023” is competitive analysis report summarizes historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/3828 . Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever